SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-061502
Filing Date
2011-11-04
Accepted
2011-11-04 20:32:19
Documents
1
Period of Report
2011-11-02

Document Format Files

Seq Description Document Type Size
1 form445481_20111104083217-.html 4  
1 form445481_20111104083217-.xml 4 12581
  Complete submission text file 0001144204-11-061502.txt   15107
Mailing Address 2530 MERIDIAN PARKWAY 2ND FLOOR DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY 2ND FLOOR DURHAM NC 27713 (919) 806-4682
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 111182556

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 111182555

Mailing Address 667 MADISON AVE 21ST FLOOR, NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR, NEW YORK NY 10065 212-339-5600
Baker Biotech Capital (GP), LLC (Reporting) CIK: 0001244389 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 111182557